Navigation Links
Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series
Date:2/13/2009

Business Executives, Pricing Analysts, and IP Professionals Meet on Expanding their Combination Products Research and Partnerships on June 1-2, 2009 in Cambridge, MA.

Needham, MA (PRWEB) February 13, 2009 -- The Pharmaceutical Strategy Series, a division of Cambridge Healthtech Institute, recently posted details for its next executive forum - Combination Products: Improving Product Life Cycles, Extending Lines, and Creating Novel Therapeutics to be held on June 1-2, 2009 at the Royal Sonesta Hotel in Cambridge, MA. This executive forum will focus on the practical interplay between combination product research, development challenges, and commercial and partnering strategies, as well as the implications for successful market realization.

Session Topics include:

  • Creative Product Development, Portfolio Management, and Line Extension Strategies using Combination Products
  • Regulatory Implications - Anticipating Regulatory Hurdles and New Developments
  • The Market Advantage of Combination Products - Analysis and Strategies for Positioning
  • Commercial Strategies for Success - Market Acceptance and Reimbursement
  • Development Challenges of Combination Products

According to Micah Lieberman, Executive Director of the Pharmaceutical Strategy Series, "We are delighted to have organized this executive forum for the pharmaceutical, biologics and medical devices industries to help companies leverage new business opportunities and intellectual property for their existing (and future) products. Pharmaceutical Strategy Series' executive forums have become known as networking platforms that bring together senior-level executives, analysts, and industry experts. I am also pleased to announce the support of Epstein Becker & Green, P.C. as our sponsor," states Lieberman.

Bradley Merrill Thompson, General Counsel to the Combination Products Coalition and Shareholder at Epstein Becker & Green, P.C. commented: "We look forward to present our perspective on overcoming the regulatory hurdles with combination products. To be compliant and competitive in the marketplace, combination product companies must stay current with regulatory developments and initiatives impacting the combination product industry. Delegates attending this conference will be better positioned to ensure the success of their company's combination products," says Thompson.

Prior to the start of this executive forum will be a pre-conference workshop: Economic Value-Based Product Design for Combination Drugs.

For full details and to register for the conference and/or pre-conference workshop, visit www.healthtech.com/CTX/overview.aspx

To receive a press pass, email Tracey Fielding at tfielding@healthtech.com

About Cambridge Healthtech Institute
Founded in 1992, Cambridge Healthtech Institute (www.chicorporate.com) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About The Pharmaceutical Strategy Series
A division of Cambridge Healthtech Institute, the Pharmaceutical Strategy Series (www.PharmaSeries.com) produces executive-level conferences that bring together R&D leaders and corporate executives to assess business opportunities, enhance corporate value, and forecast the economic and regulatory landscape within the rapidly changing pharmaceutical & biotechnology industries. PSS conferences are uniquely designed to maximize peer-to-peer networking and idea sharing.

Contact:
James Prudhomme
Cambridge Healthtech Institute
(781) 972-5400

# # #

Read the full story at http://www.prweb.com/releases/2009/02/prweb2051004.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy
2. Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
3. If Herceptin is Approved in Combination With Other Emerging Therapies it Will be in a Position to Retain Patient Share From Tykerb/Tyverb for the Treatment of HER2-Positive Breast Cancer
4. Drug combinations key in treating neurodegenerative diseases
5. InterMune Reports Results from Triple Combination Study of ITMN-191
6. Scientists call up stem cell troops to repair the body using new drug combinations
7. DrScore.com Identifies Toxic Combination
8. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
9. Drug Combinations Putting Seniors at Risk
10. Holiday Treats and Decorations Can Be a Deadly Combination for Pets
11. QLT announces interim results of radical study evaluating Visudyne combination therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology: